Epicore BioNetworks IncTSXV: EBN

Epicore BioNetworks Inc. Announces New Board Director

· Issued by Epicore BioNetworks Inc via CNW

CALGARY, Oct. 20 /CNW/ - The Board of Directors of Epicore BioNetworks Inc. is pleased to announce a new director has joined the board, effective October 15, 2008. The Board welcomes Mr. Michael Perrault of Montreal, Quebec, Canada.

Mr. Perrault is co-founder and president of Simpler Networks Inc of Montreal, Canada. He has twenty-five years experience in business development and operations management in the technology field. He has raised over $100 million in financing for his start-up companies. Mr. Perrault holds an honors degree in engineering and a master's degree in business administration from McGill University. The Board expects that his knowledge and experience, particularly in the area of strategic partnerships will be of great benefit to Epicore as it embarks on a more aggressive business development program.

The Board of Directors has approved issuance to Mr. Perrault of 150,000 options to buy Epicore common shares, pursuant to the terms of the Company's stock option program. The shares will be priced at Cdn $0.10 per share.

Epicore BioNetworks Inc. is a leading producer of environmental biotechnology and animal nutrition products. It manufactures in the USA and markets worldwide to a variety of industries to reduce environmental pollution and increase operational productivity.

Epicore BioNetworks Inc. is a public corporation with a registered office in Calgary, Alberta, Canada and with shares listed on the TSX Venture Exchange (symbol EBN). (The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.)

This press release contains forward-looking statements that involve significant risks and uncertainties. The actual results, performance or achievements of the Company might differ materially from the results, performance or achievements of the Company expressed or implied by such forward-looking statements. Such forward-looking statements include, without limitation, those regarding the development plans of the Company and the expected timing and results of such development. We can provide no assurance that such development will proceed as currently anticipated or that the expected timing or results of such development will be realized. We are subject to various risks, including the uncertainties of product development, markets for our products and regulatory review, our need for additional capital to fund our operations, our reliance on collaborative partners, our history of losses, and other risks inherent in the biotechnology industry.

Epicore BioNetworks Inc on 6ix

Story so far

Earlier from Epicore BioNetworks

Later from Epicore BioNetworks

All Epicore BioNetworks news releases